Acumen Pharmaceuticals Inc Earnings
The next earnings date for Acumen Pharmaceuticals Inc has not yet been scheduled.
Analyst Estimates of Acumen Pharmaceuticals Inc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Acumen Pharmaceuticals Inc Earnings: Historical
| 08/12/2026 | Before Market | $-0.45 | -15.38% |
| 05/12/2026 | Before Market | $-0.33 | 28.26% |
| 03/30/2026 | --- | $-0.41 | 10.05% |
| 11/12/2025 | Before Market | $-0.44 | 35.29% |
| 08/12/2025 | Before Market | $-0.68 | -30.77% |
| 05/13/2025 | Before Market | $-0.48 | 12.73% |
| 03/24/2025 | Before Market | $-0.62 | -69.49% |
| 11/12/2024 | Before Market | $-0.50 | -66.67% |
| 08/13/2024 | Before Market | $-0.34 | -36.00% |
| 05/14/2024 | Before Market | $-0.25 | -8.70% |
More About Acumen Pharmaceuticals Inc
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.
“Acumen Pharmaceuticals Inc Earnings” Can Refer to the Acumen Pharmaceuticals Inc Earnings Date
Some people say “Acumen Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Acumen Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Acumen Pharmaceuticals Inc Stock on the Earnings Date
If you own Acumen Pharmaceuticals Inc stock (ABOS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Acumen Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Acumen Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Acumen Pharmaceuticals Inc Earnings
You can contact us any time if you would like to ask questions about Acumen Pharmaceuticals Inc earnings or anything else related to the stock market.